Watch Ticker

FibroBiologics, Inc. Common Stock

Go to FibroBiologics, Inc. Common Stock Website

$0.57

-0.04 (-6.97%)

Live

Previous Close

$0.6085

Day Range

$0.5603 - $0.6299

Previous Day Range

$0.605 - $0.65

Market Cap

$26.8 million USD

Day Vol.

638687

Previous Day Vol.

418673

Currency

USD

Primary Exchange

None

FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including degenerative disc disease, multiple scle...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - FibroBiologics annonce des progrès scientifiques suite à la confirmation des résultats relatifs à la réparation de tissus cérébraux

FibroBiologics, a clinical-stage biotechnology company, has demonstrated that fibroblasts administered intravenously can facilitate remyelination in an animal model of Cuprizone-induced demyelination. This finding builds on the company's previous report on remyelination in an experimental autoimmune encephalomyelitis (EAE) animal model, providing hope for the development of transformative fibroblast-based therapies for demyelinating diseases like multiple sclerosis.

Related tickers: FBLG.

Read Full Article

N/A - FibroBiologics gibt wissenschaftlicher Fortschritte bei der Reparatur von Hirngewebe bekannt

FibroBiologics, a clinical-stage biotech company, has demonstrated that intravenous fibroblasts can promote remyelination in a preclinical model of multiple sclerosis. This finding suggests the potential of fibroblast-based therapies for treating demyelinating diseases.

Related tickers: FBLG.

Read Full Article

Trending Tickers

Please sign in to view